report by BlackRock
Results for ""
Market Outlooks
How Will Economics & Politics Shape Markets in H2 2020?
Dr. Christopher Smart, Head of the Barings Investment Institute, discusses the second half outlook including views on the current recovery, U.S./China trade skirmishes and the U.S. presidential election. Don’t miss his 10 one-word answers to our most difficult questions.
Market Outlooks
Weekly Wire: Dr. Copper’s Prognosis
This piece is approved to use with clients.
When it comes to doctors, there are a lot. The list includes famous (real) ones like Jonas Salk, Neil deGrasse Tyson, Marie Curie; famous (fictional) ones like Dr. Evil, Meredith Grey, Marcus Welby; and famous doctors who really aren’t doctors but go by the title, including the late Jazz musician Dr. John and the great Julius “Dr. J” Erving (remember, Brinker Capital is a Philadelphia-based company).
Market Outlooks
Dr. Copper’s Prognosis
When it comes to doctors, there are a lot. The list includes famous (real) ones like Jonas Salk, Neil deGrasse Tyson, Marie Curie; famous (fictional) ones like Dr. Evil, Meredith Grey, Marcus Welby; and famous doctors who really aren’t . . .
Market Outlooks
Weekly Macro Update: The “Pandemic Put” Can’t Last Forever
This piece is approved to use with clients.
As the second half comes into focus, investors will have to contemplate a world in which the risks remain—and the backstops come with strings.
Market Outlooks
Weekly Wire: With apologies to the Dave Brubeck Quartet, here’s our “Take Five”
This piece is approved to use with clients.
Even casual fans of jazz – which we believe to be the great American art form – can easily recognize the opening cords to The Dave Brubeck Quartet’s classic, “Take Five.” Released in 1959 and penned by the quartet’s alto saxophonist Paul Desmond, “Take Five” was the first jazz single to sell one million copies and is the biggest selling jazz single of all time. So, with apologies to the great Dave Brubeck and The Dave Brubeck Quartet, here is our “Take Five,” or five things we think are worth thinking about as we move into the second half of 2020.
Market Outlooks
Vlog: Quarter-end Q&A 2Q2020
Tim Holland, CFA, Global Investment Strategist, asks and answers three top-of-mind questions as investors receive their quarterly statements and reflect on the past quarter.
Market Outlooks
Weekly Macro Update: The Trough Is In—Let The Healing Begin
This piece is approved to use with clients.
While there is still a long path to recovery, global June flash PMIs confirmed we have passed the trough as contraction eased. The U.S. Employment report will be released next week, and the pressure is on for Britain and Japan to come up with a deal.
Market Outlooks
Don’t fight the Fed. And, maybe the Federal Government too
Among the better-known Wall Street maxims is “Don’t fight the Fed,” which speaks to the idea that monetary policy and the trend in interest rates determines the direction of the stock market.
Market Outlooks
Weekly Macro Update: The Irrelevant Election
This piece is approved to use with clients.
With voters so divided and angry, the outcome on November 3 will be consequential for many reasons—just not for the stock market.
Market Outlooks
Two bits of good news. And, what are two bits, anyway?
The economic headlines of late have been driven by – and understandably so – BIG pieces of news, both bad and good.
Market Outlooks
Weekly Macro Update: Will Europe Waste The Crisis?
This piece is approved to use with clients.
Investors should be rooting for EU leaders as they attempt reforms that do more than just ease the immediate pain.
Market Outlooks
[Webinar Replay] From Volatility to Opportunity in Emerging Markets Debt
This piece is approved to use with clients.
COVID-19, lower oil prices and the related shock to the global economy have weighed heavily on emerging markets debt—but opportunities have emerged as well. Join us as Barings’ EMD team shares their latest market views and discusses how they are navigating the current environment.